TGF-2signaling in thymic epithelial cells regulates thymic involution and postirradiation reconstitution

Blood

Volumn 112, Issue 3, 2008, Pages 626-634

  Hauri Hohl, Mathias M ^a   Zuklys, Saulius ^a   Keller, Marcel P ^a   Jeker, Lukas T ^a   Barthlott, Thomas ^a   Moon, Anne M ^b   Roes, Jürgen ^c   Holländer, Georg A ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; MYELOABLATIVE CONDITIONING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE; STROMA CELL; THYMOCYTE; THYMUS; ANIMAL; CYTOLOGY; PHYSIOLOGY; REGENERATION; SIGNAL TRANSDUCTION;

AGING; ANIMALS; EPITHELIAL CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MICE; REGENERATION; SIGNAL TRANSDUCTION; STROMAL CELLS; THYMUS GLAND; TRANSFORMING GROWTH FACTOR BETA;

EID: 50949123978     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-10-115618     Document Type: Article

References (61)

1. Ye M, Graf T. Early decisions in lymphoid development. Curr Opin Immunol. 2007;19:123-128.
2. Holländer G, Gill Zuklys S, Iwanami N, Liu C, Takahama Y. Cellular and molecular events during early thymus development. Immunol Rev. 2006;209:28-46.
3. Anderson G, Jenkinson EJ. Lymphostromal interactions in thymic development and function. Nat Rev Immunol. 2001;1:31-40.
4. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396: 690-695.
5. Steinmann GG. Changes in the human thymus during aging. Curr Top Pathol. 1986;75:43-88.
6. Taub DD, Longo DL. Insights into thymic aging and regeneration. Immunol Rev. 2005;205:72-93.
7. Ortman CL, Dittmar KA, Witte PL, Le PT. Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments. Int Immunol. 2002;14:813-822.
8. Gray DH, Seach N, Ueno T, et al. Developmental kinetics, turnover and stimulatory capacity of thymic epithelial cells. Blood. 2006;108:3777-3785.
9. Heng TS, Goldberg GL, Gray DH, Sutherland JS, Chidgey AP, Boyd RL. Effects of castration on thymocyte development in two different models of thymic involution. J Immunol. 2005;175:2982-2993.
10. Sutherland JS, Goldberg GL, Hammett MV, et al. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol. 2005;175:2741-2753.
11. Zediak VP, Maillard I, Bhandoola A. Multiple prethymic defects underlie age-related loss of T progenitor competence. Blood. 2007;110:1161-1167.
12. Aspinall R. T cell development, ageing and Interleukin-7. Mech Ageing Dev. 2006;127:572-578.
13. Sano S, Takahama Y, Sugawara T, et al. Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. Immunity. 2001;15:261-273.
14. Li L, Hsu HC, Stockard CR, et al. IL-12 inhibits thymic involution by enhancing IL-7- and IL-2-induced thymocyte proliferation. J Immunol. 2004;172:2909-2916.
15. Hsu HC, Li L, Zhang HG, Mountz JD. Genetic regulation of thymic involution. Mech Ageing Dev. 2005;126:87-97.
16. Govinden R, Bhoola KD. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther. 2003;98:257-265.
17. Massagué J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol. 2000;1:169-178.
18. Fortunel NO, Hatzfeld A, Hatzfeld JA. Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood. 2000;96:2022-2036.
19. Ellingsworth LR, Nakayama D, Segarini P, Dasch J, Carrillo P, Waegell W. Transforming growth factor-beta s are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation. Cell Immunol. 1988;114:41-54.
20. Kehrl JH, Wakefield LM, Roberts AB, et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986;163: 1037-1050.
21. Takahama Y, Letterio JJ, Suzuki H, Farr AG, Singer A. Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing transforming growth factor beta. J Exp Med. 1994;179:1495-1506.
22. Cerwenka A, Bevec D, Majdic O, Knapp W, Holter W. TGF-beta 1 is a potent inducer of human effector T cells. J Immunol. 1994;153:4367-4377.
23. Weller M, Constam DB, Malipiero U, Fontana A. Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression. Eur J Immunol. 1994;24:1293-1300.
24. Chen W, Jin W, Tian H, et al. Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J Exp Med. 2001;194:439-453.
25. Swain SL, Huston G, Tonkonogy S, Weinberg A. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol. 1991;147:2991-3000.
26. Sad S, Mosmann TR. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J Immunol. 1994;153:3514-3522.
27. Langer JC, Henckaerts E, Orenstein J, Snoeck HW. Quantitative trait analysis reveals transforming growth factor-beta2 as a positive regulator of early hematopoietic progenitor and stem cell function. J Exp Med. 2004;199:5-14.
28. Schmid P, Cox D, Bilbe G, Maier R, McMaster GK. Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. Development. 1991;111:117-130.
29. Proetzel G, Pawlowski SA, Wiles MV, et al. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet. 1995;11:409-414.
30. Sanford LP, Ormsby I, Gittenberger-de Groot AC, et al. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development. 1997;124:2659-2670.
31. Oshima M, Oshima H, Taketo MM. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol. 1996;179:297-302.
32. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699.
33. Cazac BB, Roes J. TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity. 2000;13:443-451.
34. Macatee TL, Hammond BP, Arenkiel BR, Francis L, Frank DU. Moon AM. Ablation of specific expression domains reveals discrete functions of ectoderm- and endoderm-derived FGF8 during cardiovascular and pharyngeal development. Development. 2003;130:6361-6374.
35. Rossi SW, Jeker LT, Ueno T, et al. Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. Blood. 2007;109:3803-3811.
36. Hauri-Hohl MM, Keller MP, Gill J, et al. DonorT-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation. Blood. 2007;109:4080-4088.
37. Anderson G, Jenkinson EJ, Moore NC, Owen JJ. MHC class II-positive epithelium and mesenchyme cells are both required for T-cell development in the thymus. Nature. 1993;362:70-73.
38. Schwarz BA, Bhandoola A. Circulating hematopoietic progenitors with T lineage potential. Nat Immunol. 2004;5:953-960.
39. Gill J, Malin M, Sutherland J, Gray D, Hollander G, Boyd R. Thymic generation and regeneration. Immunol Rev. 2003;195:28-50.
40. Sempowski GD, Hale LP, Sundy JS, et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol. 2000;164:2180-2187.
41. Olsen NJ, Zhou P, Ong H, Kovacs WJ. Testosterone induces expression of transforming growth factor-beta 1 in the murine thymus. J Steroid Biochem Mol Biol. 1993;45:327-332.
42. Hobson KG, Cho K, Adamson LK, Greenhalgh DG. Burn-induced thymic apoptosis corresponds with altered TGF-beta(1) and Smad 2/3. J Surg Res. 2002;105:4-9.
43. Kasai M, Hirokawa K, Kajino K, et al. Difference in antigen presentation pathways between cortical and medullary thymic epithelial cells. Eur J Immunol. 1996;26:2101-2107.
44. Meilin A, Shoham J, Schreiber L, Sharabi Y. The role of thymocytes in regulating thymic epithelial cell growth and function. Scand J Immunol. 1995;42:185-190.
45. Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 2004;427:355-360.
46. Ehrhart EJ, Segarini P, Tsang ML. Carroll AG, Barcellos-Hoff MH. Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation. FASEB J. 1997;11:991-1002.
47. Chen W, Frank ME, Jin W, Wahl SM. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity. 2001;14: 715-725.
48. Ewan KB, Henshall-Powell RL, Ravani SA, et al. Transforming growth factor-beta1 mediates cellular response to DNA damage in situ. Cancer Res. 2002;62:5627-5631.
49. Letterio JJTGF-beta signaling in T cells: roles in lymphoid and epithelial neoplasia. Oncogene. 2005;24:5701-5712.
50. Graham A. The development and evolution of the pharyngeal arches. J Anat. 2001;199:133-141.
51. Hagedorn L, Floris J, Suter U, Sommer L. Autonomic neurogenesis and apoptosis are alternative fates of progenitor cell communities induced by TGFbeta. Dev Biol. 2000;228:57-72.
52. Shah NM, Groves AK, Anderson DJ. Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members. Cell. 1996;85: 331-343.
53. Hagedorn L, Suter U, Sommer L. P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. Development. 1999;126: 3781-3794.
54. Wurdak H, Ittner LM, Lang KS, et al. Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome. Genes Dev. 2005;19:530-535.
55. Bockman DE, Kirby ML. Dependence of thymus development on derivatives of the neural crest. Science. 1984;223:498-500.
56. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB. Maternal rescue of transforming growth factor-beta 1 null mice. Science. 1994;264:1936-1938.
57. Kumar R, Langer JC, Snoeck HW. Transforming growth factor-beta2 is involved in quantitative genetic variation in thymic involution. Blood. 2006;107:1974-1979.
58. Chantry D, Turner M, Feldmann M. Interleukin 7 (murine pre-B cell growth factor/lymphopoietin 1) stimulates thymocyte growth: regulation by transforming growth factor beta. Eur J Immunol. 1989;19:783-786.
59. Schluns KS, Cook JE, Le PT. TGF-beta differentially modulates epidermal growth factormediated increases in leukemia-inhibitory factor, IL-6, IL-1 alpha, and IL-1 beta in human thymic epithelial cells. J Immunol. 1997;158:2704-2712.
60. Wright N, de Lera TL, García-Moruja C, et al. Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion. Blood. 2003;102:1978-1984.
61. Agus DB, Surh CD, Sprent J. Reentry of T cells to the adult thymus is restricted to activated T cells. J Exp Med. 1991;173:1039-1046.